[aaavl2821]

just wrote a blog post on this exact topic for the biopharma industry: https://newbio.tech/blog/bio_charts.html

its a $600B industry that is in decline because its traditional R&D engine is sputtering out, and big pharma has been amazingly acquisitive the last five years to replace off-patent blockbuster drugs (more IPOs and big M&A than software the last 5 years despite getting 1/5 of venture funding)

tons of really interesting new tech for startups to explore: synthetic biology, cell and gene therapy, bioelectronic medicine, many many others